# Themis Medicare Ltd (THEMISMED)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹98.64
Day Change: +1.21%
52W High: ₹174.73
52W Low: ₹64.95
Market Cap: ₹912 Cr

## Valuation
P/E: 0
P/B: 2.39
EPS: ₹-1.89
Book Value: ₹40.99
Dividend Yield: 0%

## Returns
1Y Return: -21.24%

## Profitability
ROE: 0%
ROCE: 11.42%
Debt/Equity: 0.25
Revenue Growth: -3.9%
Profit Growth: 1716.7%
EBITDA Margin: -3.32%
Operating Margin: 7.99%

## About
Themis Medicare Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Themis Medicare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:59:11.023Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:11.023Z
Quant Updated: 2026-05-18T22:59:11.023Z
Sentiment Updated: 2026-05-18T22:59:11.023Z
Financials Status: current
Financials Updated: 2026-05-19T11:32:13.788Z
Financials Last Attempt: 2026-05-19T11:32:13.788Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹400.08 Cr
Operating Profit: ₹39.15 Cr (OPM 9.79%)
Net Profit: ₹29.83 Cr
Tax: ₹9.84 Cr

## Annual P&L History
FY25: Rev ₹400.08Cr | PAT ₹29.83Cr | OPM 9.79%
FY24: Rev ₹376.63Cr | PAT ₹43.52Cr | OPM 10.42%
FY23: Rev ₹344.46Cr | PAT ₹56.9Cr | OPM 16.54%

## Balance Sheet (FY25)
Total Assets: ₹588.03 Cr
Total Liabilities: ₹185.43 Cr
Borrowings: ₹82.99 Cr
Cash: ₹6.56 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Dinesh Shantilal Patel CChem., FRSC(Lond.), Ph.D., Executive Chairman
- Sachin Dinesh Patel CChem., Ph.D., CEO, MD & Executive Director
- Tushar J. Dalal A.C.A., Chief Financial Officer
- Raj  Kumar, General Manager of Operations
- Reena Sachin Patel, VP of Systems & Administration

---
Source: rupiya.io/stocks/themismed
Disclaimer: For research and education only. Not investment advice.